Lv0
0 积分 2025-02-23 加入
Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the phase II RC48-C017 trial
1天前
已完结
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study
1天前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
1天前
已完结
Current Disease Management of Primary Urethral Carcinoma
24天前
已完结
[Applications of Naked-Eye 3D Display Technology in Medical Field]
2个月前
已完结
Recurrent Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Treatment
2个月前
已关闭
Hyperkalemia in both surgically and medically treated patients with primary aldosteronism
2个月前
已完结
Immune checkpoint inhibition in upper tract urothelial carcinoma
2个月前
已完结
Clavien-Dindo classificationa: a tool to assess complications following surgical treatment in children with acute appendicitis
3个月前
已完结
The Self‐Estimation Index of Erectile Function‐No Sexual Intercourse (SIEF‐NS): A Multidimensional Scale to Assess Erectile Dysfunction in the Absence of Sexual Intercourse
3个月前
已完结
皖公网安备34019202002308
